not tagged
cel-sci
['head and neck', 'cel-sci']
cel-sci s phase 3 data presented at esmo 2022: neoadjuvant multikine achieved groundbreaking tumor response &amp; extended overall survival in locally advanced head and neck cancer 
Breaking news from Business Wire